Pro-Pointer, Inc. Executes Share Exchange Agreement With Privately Held Coenzyme-A Technologies, Inc.
2009年8月28日 - 10:30PM
Marketwired
Pro-Pointer, Inc. (PINKSHEETS: PPII) announced today that they have
entered into a share exchange agreement with Coenzyme-A
Technologies, Inc., a privately held innovative company that has
applied new technology to the formulation and manufacture of a
series of proprietary products which address nutritional
deficiencies that result from the stress of modern day living,
chemical imbalances within the body, and the effects of aging.
Under the terms of the share exchange agreement, Pro-Pointer will
issue additional common stock equaling approximately 78% ownership
of Pro-Pointer (including subsequent share issuances) in exchange
for 100% of the issued and outstanding shares of Coenzyme-A
Technologies, Inc. Subsequent to the closing of the share exchange
agreement new directors and officers of the Company will be
appointed.
ABOUT COENZYME-A TECHNOLOGIES, INC.
Coenzyme-A Tech. Inc. is a science-based company primarily
engaged in the development of nutraceutical supplements and
uniquely efficacious and patentable skin and hair care products to
be available without prescription. These products are designed to
make skin and hair look and feel younger on a sustained basis by
attacking the cellular causes of skin aging and decreased hair
density. Company website -- www.coenzyme-a.com
FORWARD-LOOKING STATEMENTS
The information contained in this news release, other than
historical information, consists of forward-looking statements
within the meaning of Section 27A of the Securities Act and Section
21E of the Exchange Act. These statements may involve risks and
uncertainties that could cause actual results to differ materially
from those described in such statements. Such forward-looking
statements involve known and unknown risks and uncertainties,
including all business uncertainties relating to product
development, marketing, market acceptance, future capital
requirements, competition in general and other factors that may
cause actual results to be materially different from those
described herein as anticipated, believed, estimated or expected.
The Company is under no obligation to (and expressly disclaims any
such obligation to) update or alter its forward-looking statements
whether as a result of new information, future events or
otherwise.
Investor Relations InvestSource Inc. 714-847-2460 ext 801 Email
Contact
Coenzyme A (CE) (USOTC:PPII)
過去 株価チャート
から 2 2025 まで 3 2025
Coenzyme A (CE) (USOTC:PPII)
過去 株価チャート
から 3 2024 まで 3 2025
Real-Time news about Coenzyme A Inc (CE) (その他OTC): 0 recent articles
その他のPro-Pointer, Inc.ニュース記事